BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2749040)

  • 1. [Adrenal hyperplasia of late onset: optimization of therapy by measuring the circadian variation of serum 17-OH-progesterone].
    Contreras P; Rojas A; Vega I
    Rev Med Chil; 1989 Jun; 116(6):552-7. PubMed ID: 2749040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circadian hydrocortisone infusions in patients with adrenal insufficiency and congenital adrenal hyperplasia.
    Merza Z; Rostami-Hodjegan A; Memmott A; Doane A; Ibbotson V; Newell-Price J; Tucker GT; Ross RJ
    Clin Endocrinol (Oxf); 2006 Jul; 65(1):45-50. PubMed ID: 16817818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum cortisol and 17-hydroxyprogesterone interrelation in classic 21-hydroxylase deficiency: is current replacement therapy satisfactory?
    Charmandari E; Matthews DR; Johnston A; Brook CG; Hindmarsh PC
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4679-85. PubMed ID: 11600525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3 alpha-androstanediol glucuronide in virilizing congenital adrenal hyperplasia: a useful serum metabolic marker of integrated adrenal androgen secretion.
    Pang S; MacGillivray M; Wang M; Jeffries S; Clark A; Rosenthal I; Wiegensberg M; Riddick L
    J Clin Endocrinol Metab; 1991 Jul; 73(1):166-74. PubMed ID: 2045467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronopharmacology of hydrocortisone and 9 alpha-fluorhydrocortisone in the treatment for congenital adrenal hyperplasia.
    Moeller H
    Eur J Pediatr; 1985 Nov; 144(4):370-3. PubMed ID: 4076253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cortico-adrenal-genital syndrome. Diagnosis, therapy, follow-up].
    Gargantini L; Trifirò G; Bianchi C; Chiumello G
    Pediatr Med Chir; 1985; 7(4):487-90. PubMed ID: 3016673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Defects of adrenal steroidogenesis in patients with hirsutism].
    Salinas Vert I; Audí Parera L; Granada Ybern ML; Lucas Martín A; Pizarro Lozano E; Foz Sala M; Sanmartí Sala A
    Med Clin (Barc); 1998 Feb; 110(5):171-6. PubMed ID: 9547720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for late-onset congenital adrenal hyperplasia in hirsutism or amenorrhea.
    Baskin HJ
    Arch Intern Med; 1987 May; 147(5):847-8. PubMed ID: 3579438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modified-release hydrocortisone for circadian therapy: a proof-of-principle study in dexamethasone-suppressed normal volunteers.
    Newell-Price J; Whiteman M; Rostami-Hodjegan A; Darzy K; Shalet S; Tucker GT; Ross RJ
    Clin Endocrinol (Oxf); 2008 Jan; 68(1):130-5. PubMed ID: 17803699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morning steroid profile in children with congenital adrenal hyperplasia under different hydrocortisone schedules.
    Silva IN; Oliveira-Júnior DF; Simal CJ; Viana MB; Chagas AJ
    Indian J Pediatr; 1994; 61(4):341-6. PubMed ID: 8002061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma progesterone and 17-hydroxyprogesterone in normal men and children with congenital adrenal hyperplasia.
    Strott CA; Yoshimi T; Lipsett MB
    J Clin Invest; 1969 May; 48(5):930-9. PubMed ID: 4305376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of late-onset adrenal hyperplasia in girls with peripubertal virilization.
    Sólyom J; Gács G; Keszei K; Láng K; Orley J; Petheö I; Ságodi L
    Acta Endocrinol (Copenh); 1987 Jul; 115(3):413-8. PubMed ID: 3039770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Daily profiles of salivary cortisol in hydrocortisone treated children with congenital adrenal hyperplasia.
    Hampl R; Foretová L; Sulcová J; Stárka L
    Eur J Pediatr; 1990 Jan; 149(4):232-4. PubMed ID: 2303071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of virilizing adrenal hyperplasia in adolescents. Use and side-effects of dexamethasone].
    Job JC; Munck A; Chaussain JL; Canlorbe P
    Arch Fr Pediatr; 1985 Nov; 42(9):765-9. PubMed ID: 4083978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control in congenital adrenal hyperplasia monitored by frequent saliva 17OH-progesterone measurements.
    Hughes IA; Read GF
    Horm Res; 1984; 19(2):77-85. PubMed ID: 6538545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adrenalectomy as therapy in refractory adrenogenital syndrome].
    von Mühlendahl KE; Sippell WG
    Monatsschr Kinderheilkd; 1989 Jun; 137(6):341-4. PubMed ID: 2761548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenal function in early and metastatic breast cancer: dexamethasone suppression of plasma cortisol.
    Drafta DS; Stroe E; Schindler EE; Teodosiu T; Gozariu L; Drafta D
    Endocrinologie; 1981; 19(2):115-21. PubMed ID: 6789444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Andrenogenital syndrome (author's transl)].
    Nieschlag E; Wenner H; Breu H; Wickings EJ; Schellong G
    Dtsch Med Wochenschr; 1980 Apr; 105(17):600-3. PubMed ID: 7371512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of three glucocorticoid suppressive regimes in adults with congenital adrenal hyperplasia.
    Horrocks PM; London DR
    Clin Endocrinol (Oxf); 1982 Dec; 17(6):547-56. PubMed ID: 6299623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Malignant arterial hypertension disclosing late congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency].
    Ribstein J; Sciolla JP; Barjon P; Sultan C; Forest M; de Peretti E
    Arch Mal Coeur Vaiss; 1988 Jun; 81 Spec No():93-5. PubMed ID: 3142437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.